
StudyFinder
BEGIN-OB-19: A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)

Recruiting
This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective CFTR modulators and their impact in children with CF on endocrine growth factors, the gut microbiome, respiratory microbiome, liver and pancreatic function, lung function, sweat chloride, and inflammatory markers.
Cystic Fibrosis
CF, CFTR Modulator, Cystic Fibrosis, elexacaftor, ivacaftor, tezacaftor, triple combination therapy
Dena Johnson - joh20459@umn.edu
Elissa Downs
NA
STUDY00010861
NCT04509050
See this study on ClinicalTrials.gov